Magenta therapeutics, inc. (MGTA)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17
Assets
Current assets:
Cash and cash equivalents

74,933

65,071

85,507

33,111

31,241

58,345

159,674

173,429

51,402

Marketable securities

55,473

80,658

75,063

139,162

96,066

84,225

-

-

-

Restricted cash

-

-

-

-

-

-

165

165

165

Prepaid expenses and other current assets

2,726

4,114

4,660

10,740

7,770

2,751

3,025

2,332

936

Total current assets

133,132

149,843

165,230

183,013

135,077

145,321

162,864

175,926

52,503

Restricted cash

1,780

1,780

1,780

1,780

1,780

1,780

1,780

1,780

-

Property and equipment, net

9,529

9,891

10,223

10,648

10,640

10,212

8,149

2,912

1,956

Deferred offering costs

-

-

-

-

195

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

4

Total assets

144,441

161,514

177,233

195,441

147,692

157,313

172,793

180,618

54,463

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

3,947

2,812

2,038

2,349

3,010

3,492

4,897

1,497

167

Accrued expenses and other current liabilities

8,756

11,303

7,591

7,591

4,910

6,927

7,032

6,108

3,975

Total current liabilities

12,703

14,115

9,629

9,940

7,920

10,419

11,929

7,605

4,142

Deferred rent

6,337

6,206

6,075

5,945

5,769

1,246

-

-

-

Long-term liabilities

-

-

-

-

-

-

1,080

796

-

Total liabilities

19,040

20,321

15,704

15,885

13,689

11,665

13,009

8,401

4,142

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

-

Redeemable convertible preferred stock (Series A and B), $0.001 par value; no shares and 49,178,527 shares authorized, issued and outstanding as of December 31, 2018 and 2017, respectively

-

-

-

-

-

-

-

-

92,439

Stockholders' Equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding

-

-

-

-

-

-

0

0

-

Common stock, $0.001 par value; 150,000,000 shares authorized; 39,588,739 shares and 39,466,254 shares issued and 39,454,635 shares and 39,260,532 shares outstanding as of March 31, 2020 and December 31, 2019, respectively

39

39

39

39

34

33

33

33

2

Additional paid-in capital

324,505

320,641

317,665

314,646

251,488

248,349

245,798

242,216

3,091

Accumulated other comprehensive income

363

8

83

139

41

-8

-

-

-

Accumulated deficit

-199,506

-179,495

-156,258

-135,268

-117,560

-102,726

-86,047

-70,032

-45,211

Total stockholders' equity

125,401

141,193

161,529

179,556

134,003

145,648

159,784

172,217

-42,118

Total liabilities and stockholders' equity

144,441

161,514

177,233

195,441

147,692

157,313

172,793

180,618

54,463